Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast Cancer

NCT03904173 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT03904173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03904173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast Cancer
Lead sponsor
Oslo University Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
October 29, 2018
Completion date
December 31, 2043
Enrollment
2,300 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast neoplasms, hormone receptor positive tumor